FEDERATED MDTA LLC
Follow13F filer, CIK 1056508, BOSTON, MA
FEDERATED MDTA LLC filed a 13F-NT notice for the quarter ended 2025-12-31 on 2026-02-12.
Filed (acceptance time not in the bulk data set), ingested 13F-NT 0001623632-26-000253
This filer reports no holdings of its own for Q4 2025. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.
Changes against Q3 2025 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.
Stakes and trades reported after 2025-12-31
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- LFMD LIFEMD INC: 13G/A 4,049,974 shares, 8.4% of the class, 13G/A filed 2026-10-07, 0001623632-26-001552Timeline
Accepted , ingested - EYPT EYEPOINT INC: 13G/A 6,934,414 shares, 8.04% of the class, 13G/A filed 2026-10-07, 0001623632-26-001550Timeline
Accepted , ingested - ATYR ATYR PHARMA INC: 13G/A 4,965,414 shares, 5.06% of the class, 13G/A filed 2026-10-07, 0001623632-26-001548Timeline
Accepted , ingested - ARCT ARCTURUS THERAPEUTICS HLDGS: 13G/A 1,678,069 shares, 5.9% of the class, 13G/A filed 2026-10-07, 0001623632-26-001546Timeline
Accepted , ingested
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-NT 0001623632-26-000253 | notice | 2026-02-12 | acceptance time not in the bulk data set |